NSC |
Compound |
Enrichment |
Correlation |
NSC 763059 |
Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride |
0.0100967765290133 |
0.17580694 |
NSC 79093 |
5-Hydroxy-6,7,8,4'-tetramethoxyflavone |
0.0100967765290133 |
0.46370724 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0135588245836371 |
0.38388351 |
NSC 3077 |
s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) |
0.0135588245836371 |
0.21464107 |
NSC 339579 |
7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate |
0.0135588245836371 |
0.31039405 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0135588245836371 |
0.29210971 |
NSC 354974 |
Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- |
0.0135588245836371 |
0.31939984 |
NSC 359239 |
Antibiotic X-14766A |
0.0135588245836371 |
0.038525949 |
NSC 637411 |
Null |
0.0135588245836371 |
0.18353621 |
NSC 647763 |
Jasplakinolide epoxide C |
0.0135588245836371 |
0.1066716 |